Institut Für Pharmakologie Und Präventive Medizin

This study will follow 500 patients in Europe for 10 years after they receive a specific type of replacement heart valve called the SAPIEN 3 Ultra RESILIA. The goal is to see how well the valve works and holds up over a long period, especially as more younger patients receive the…